VRTX

Vertex Pharmaceuticals Inc

437.60

-9.95-2.22%

Opening14:22 06/01 EDT

Daily

Weekly

Monthly

Quarterly

Yearly

OPEN/PREV CLOSE439.91/447.54

TODAY RANGE433.26-443.54

VOL516.33K

MARKET CAP111.06B

52 WEEK RANGE362.50-507.92

AVG VOL (3M)1.30M

% TURNOVER0.20%

TURNOVER--

P/E (TTM)25.94

% RANGE2.30%

EPS(TTM)16.87

P/E(FORWARD)25.66

P/B5.74

BVPS76.18

DIVIDEND--

P/S9.26

BETA--

DIV YIELD0.00%

FREE FLOAT MKT CAP110.82B

SHARES OUTSTANDING253.81M

NEXT EARNINGS08/03-08/07

FREE FLOAT253.24M

LOT SIZE1

EX-DATE08/24/2000

News

Press Releases

Financial Reports

Profile

NASDAQ·2h ago
Noteworthy ETF Outflows: CGUS, RTX, VRTX, LIN
TipRanks·5h ago
Vertex announces U.S. FDA accepted BLA submission for povetacicept
PUBT·6h ago
Vertex says FDA accepts BLA for povetacicept in IgA nephropathy, sets Nov. 30, 2026 action date
Reuters·6h ago
VERTEX PHARMACEUTICALS - FDA SETS PDUFA DATE FOR POVETACICEPT ON NOVEMBER 30, 2026
Seeking Alpha·5d ago
Portfolio check: The biggest SA Quant upgrades over the past week
Reuters·5d ago
VERTEX PHARMACEUTICALS INC <VRTX.O>: TRUIST SECURITIES RAISES TARGET PRICE TO $542 FROM $525
PUBT·5d ago
Nuvalent names Georg Pirmin Meyer chief international officer
TipRanks·5d ago
Vertex Pharmaceuticals assumed with a Buy at Truist
Reuters·5d ago
U.S. RESEARCH ROUNDUP- Agilent Technologies, Fedex, Synopsys
NASDAQ·05/22 16:33
Capital Group Growth ETF Experiences Big Inflow
Seeking Alpha·05/22 14:27
BME: Discount Narrows, But A Strong Long-Term Hold Candidate Anyway
Seeking Alpha·05/21 21:40
These Are The Upcoming Catalysts For Crispr Therapeutics Stock
Dow Jones·05/21 17:28
Vertex Pharmaceuticals Says New Pain Management Drug Is Under Review at Health Canada
TipRanks·05/21 17:00
Vertex announces Health Canada acceptance of NDS for suzetrigine
Reuters·05/21 16:57
VERTEX ANNOUNCES NEW DRUG SUBMISSION FOR SUZETRIGINE HAS BEEN ACCEPTED FOR REVIEW BY HEALTH CANADA FOR THE TREATMENT OF MODERATE-TO-SEVERE ACUTE PAIN IN ADULTS

Same Industry

Name/Symbol

Change%

Price

MCK

Biogen Inc

BIIB

-0.20%

196.00

AMGN

SHPG

Bristol-Myers Squibb Company Celegne Contingent Value Rights

CELG-RT

+0.26%

0.1153

LLY

CELG

TXMD

JNJ

Abbvie Inc

ABBV

-0.42%

217.72

ZTS

GILD

Novo-Nordisk A/S

NVO

+0.15%

45.58

Bristol-Myers Squibb Co

BMY

+0.47%

57.18

Alexion Pharms

ALXN

+1.70%

182.50

PFE

SNY

GCVRZ

Novartis

NVS

-0.81%

150.17

Dr Reddys Labs

RDY

+0.81%

13.63

No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.